Role of ligand-based drug design methodologies toward the discovery of new anti- Alzheimer agents: futures perspectives in Fragment-Based Ligand Design.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Current Medicinal Chemistry

• Publication date

  2012-03-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/092986712799945058PMID 22376033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fragment-based approaches in drug discovery

  2013cited by this paper
• AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation.

  2012cited by this paper
• MISS-Prot: web server for self/non-self discrimination of protein residue networks in parasites; theory and experiments in Fasciola peptides and Anisakis allergens.

  2011cited by this paper
• Application of Bioinformatics for the Search of Novel Anti-Viral Therapies: Rational Design of Anti-Herpes Agents

  2011cited by this paper
• Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica.

  2011cited by this paper
• NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.

  2011cited by this paper
• Ligand-based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks.

  2011cited by this paper
• Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.

  2011cited by this paper
• Relationship of Adult Neurogenesis with Tau Phosphorylation and GSK-3β Activity in Subventricular Zone

  2011cited by this paper
• An application of two MIFs-based tools (Volsurf+ and Pentacle) to binary QSAR: the case of a palinurin-related data set of non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors.

  2011cited by this paper
• Multifunctional neuroprotective derivatives of rasagiline as anti-alzheimer’s disease drugs

  2011cited by this paper
• MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae.

  2011cited by this paper
• Rational design of new agrochemical fungicides using substructural descriptors.

  2011cited by this paper
• First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines

  2011influential reference
• Quantitative structure-activity relationship modelling of the carcinogenic risk of nitroso compounds using regression analysis and the TOPS-MODE approach

  2010cited by this paper
• Trypano-PPI: a web server for prediction of unique targets in trypanosome proteome by using electrostatic parameters of protein-protein interactions.

  2010cited by this paper
• QSAR, docking, and CoMFA studies of GSK3 inhibitors.

  2010cited by this paper
• Unified QSAR & network‐based computational chemistry approach to antimicrobials. II. Multiple distance and triadic census analysis of antiparasitic drugs complex networks

  2010cited by this paper
• Bond‐Based 2D Quadratic Fingerprints in QSAR Studies: Virtual and In vitro Tyrosinase Inhibitory Activity Elucidation

  2010cited by this paper
• A topological substructural molecular design approach for predicting mutagenesis end-points of alpha, beta-unsaturated carbonyl compounds.

  2010cited by this paper
• Network topological indices, drug metabolism, and distribution.

  2010cited by this paper
• Structural contributions of substrates to their binding to P-Glycoprotein. A TOPS-MODE approach.

  2010cited by this paper
• Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.

  2010cited by this paper
• A 3D-QSAR model based screen for dihydropyridine-like compound library to identify inhibitors of amyloid beta (Aβ) production

  2010cited by this paper
• Small-sample precision of ROC-related estimates

  2010cited by this paper
• Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues.

  2010cited by this paper
• Binding research on flavones as ligands of β-amyloid aggregates by fluorescence and their 3D-QSAR, docking studies.

  2010cited by this paper
• Multi-target spectral moments for QSAR and Complex Networks study of antibacterial drugs.

  2009cited by this paper
• Designing novel antitrypanosomal agents from a mixed graph‐theoretical substructural approach

  2009cited by this paper
• QSAR and complex network study of the chiral HMGR inhibitor structural diversity.

  2009cited by this paper
• Fragment-Based Drug Discovery: A Practical Approach

  2009cited by this paper
• Analysis of Complex Networks: From Biology to Linguistics

  2009cited by this paper
• Spectral theory of networks : from biomolecular to ecological systems

  2009cited by this paper
• Predictive QSAR modeling of CCR5 antagonist piperidine derivatives using chemometric tools

  2009cited by this paper
• Computational chemistry study of 3D‐structure‐function relationships for enzymes based on Markov models for protein electrostatic, HINT, and van der Waals potentials

  2009cited by this paper
• Molecular descriptors for chemoinformatics

  2009cited by this paper
• Assessment of MAO‐B Occupancy in the Brain With PET and [11C]‐L‐Deprenyl‐D2: A Dose‐Finding Study With a Novel MAO‐B Inhibitor, EVT 301

  2009cited by this paper
• Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.

  2009cited by this paper
• Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.

  2009cited by this paper
• Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3β inhibitors

  2009cited by this paper
• QSPR modelling with the topological substructural molecular design approach: beta-cyclodextrin complexation.

  2009cited by this paper
• Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors.

  2009cited by this paper
• 3D entropy and moments prediction of enzyme classes and experimental-theoretic study of peptide fingerprints in Leishmania parasites.

  2009cited by this paper
• Platelet serotonin concentration and monoamine oxidase type B activity in female patients in early, middle and late phase of Alzheimer's disease.

  2009cited by this paper
• A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.

  2009cited by this paper
• Design of novel antituberculosis compounds using graph-theoretical and substructural approaches

  2009cited by this paper
• Prediction of enzyme classes from 3D structure: a general model and examples of experimental-theoretic scoring of peptide mass fingerprints of Leishmania proteins.

  2009cited by this paper
• Feature Selection and Linear/Nonlinear Regression Methods for the Accurate Prediction of Glycogen Synthase Kinase-3β Inhibitory Activities

  2009cited by this paper
• Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.

  2008cited by this paper
• Prediction of fungicidal activities of rice blast disease based on least-squares support vector machines and project pursuit regression.

  2008cited by this paper
• Quantitative structure carcinogenicity relationship for detecting structural alerts in nitroso-compounds: species: rat; sex: male; route of administration: water.

  2008cited by this paper
• Critical Assessment of QSAR Models of Environmental Toxicity against Tetrahymena pyriformis: Focusing on Applicability Domain and Overfitting by Variable Selection

  2008cited by this paper
• Non-nucleoside inhibitors of NS5B polymerase binding to allosteric sites: 3D- QSAR and molecular docking studies.

  2008cited by this paper
• Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

  2008cited by this paper
• How the parts organize in the whole? A top-down view of molecular descriptors and properties for QSAR and drug design.

  2008cited by this paper
• Quantitative structure-carcinogenicity relationship for detecting structural alerts in nitroso compounds: species, rat; sex, female; route of administration, gavage.

  2008cited by this paper
• Enzymes/non-enzymes classification model complexity based on composition, sequence, 3D and topological indices.

  2008cited by this paper
• Antibody recognition and conformational flexibility of a plaque-specific beta-amyloid epitope modulated by non-native peptide flanking regions.

  2008cited by this paper
• Pharmacophore modeling, quantitative structure-activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3beta inhibitory activities for cimetidine, hydroxychloroquine, and gemifloxacin.

  2008cited by this paper
• Bond-based linear indices in QSAR: computational discovery of novel anti-trichomonal compounds

  2008cited by this paper
• A molecular dynamics study of the interaction of D-peptide amyloid inhibitors with their target sequence reveals a potential inhibitory pharmacophore conformation.

  2008cited by this paper
• Predicting activities without computing descriptors: graph machines for QSAR

  2007cited by this paper
• Quantitative structure carcinogenicity relationship for detecting structural alerts in nitroso-compounds.

  2007cited by this paper
• Quantitative structure-activity relationship of sesquiterpene lactones with cytotoxic activity.

  2007cited by this paper
• Increased level of active GSK‐3β in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration

  2007cited by this paper
• 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.

  2007cited by this paper
• Unified QSAR approach to antimicrobials. Part 2: predicting activity against more than 90 different species in order to halt antibacterial resistance.

  2007cited by this paper
• Probing the physicochemical and structural requirements for glycogen synthase kinase-3alpha inhibition: 2D-QSAR for 3-anilino-4-phenylmaleimides.

  2006cited by this paper
• Linear and nonlinear modeling of antifungal activity of some heterocyclic ring derivatives using multiple linear regression and Bayesian-regularized neural networks

  2006cited by this paper
• 2D Autocorrelation Modelling of the Inhibitory Activity of Cytokinin-Derived Cyclin-Dependent Kinase Inhibitors

  2006cited by this paper
• 3D QSAR for GSK-3β inhibition by indirubin analogues

  2006influential reference
• Synthesis, biological evaluation and 3D-QSAR of 1,3,5-trisubstituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase A inhibitors.

  2006cited by this paper
• 3D QSAR for GSK-3beta inhibition by indirubin analogues.

  2006cited by this paper
• Unify QSAR approach to antimicrobials. Part 1: predicting antifungal activity against different species.

  2006cited by this paper
• A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins.

  2006cited by this paper
• Modeling of Cyclin-Dependent Kinase Inhibition by 1H-Pyrazolo[3, 4-d]Pyrimidine Derivatives Using Artificial Neural Network Ensembles

  2005cited by this paper
• 3D-QSAR and Docking Studies of Selective GSK-3beta Inhibitors. Comparison with a Thieno[2, 3-b]pyrrolizinone Derivative, a New Potential Lead for GSK-3beta Ligands

  2005cited by this paper
• Chemoinformatics in Drug Discovery: OPREA:CHEMOINFORMATICS O-BK

  2005cited by this paper
• Virtual Screening in Drug Discovery

  2005cited by this paper
• Tetracycline and its analogues as inhibitors of amyloid fibrils: searching for a geometrical pharmacophore by theoretical investigation of their conformational behavior in aqueous solution

  2005cited by this paper
• Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer’s disease

  2004cited by this paper
• Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones.

  2004cited by this paper
• Creating molecular diversity from antioxidants in Brazilian propolis. Combination of TOPS-MODE QSAR and virtual structure generation

  2004cited by this paper
• GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

  2003cited by this paper
• GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

  2003cited by this paper
• Handbook of Chemoinformatics

  2003cited by this paper
• Co-use of donepezil and hypnotics among Alzheimer's disease patients living in the community.

  2003cited by this paper
• Quantitative structure-toxicity relationships using TOPS-MODE. 3. Structural factors influencing the permeability of commercial solvents through living human skin

  2003cited by this paper
• Binding models of reversible inhibitors to type-B monoamine oxidase

  2002cited by this paper
• Sporadic and Familial Cerebral Amyloid Angiopathies

  2002cited by this paper
• The Merck index : an encyclopedia of chemicals, drugs, and biologicals

  2001cited by this paper
• Recent advances on the role of topological indices in drug discovery research.

  2001cited by this paper
• A 3D QSAR Study of Monoamino Oxidase-B Inhibitors Using the Chemical Function Based Pharmacophore Generation Approach

  2001cited by this paper
• Can 3D Structural Parameters Be Predicted from 2D (Topological) Molecular Descriptors?

  2001cited by this paper
• Quantitative Structure–Toxicity Relationships Using Tops-Mode. 1. Nitrobenzene Toxicity to Tetrahymena Pyriformis

  2001cited by this paper
• A novel approach for the virtual screening and rational design of anticancer compounds.

  2000cited by this paper
• Selective inhibitors and computer modelling of the active site of monoamine oxidase.

  2000cited by this paper
• Molecular determinants of MAO selectivity in a series of indolylmethylamine derivatives: biological activities, 3D-QSAR/CoMFA analysis, and computational simulation of ligand recognition.

  2000cited by this paper
• Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs.

  2000cited by this paper
• In silico studies for the rational discovery of anticonvulsant compounds.

  2000cited by this paper

• Mechanisms to medicines: navigating drug repurposing strategies in Alzheimer’s disease

  2026cites this paper
• Cheminformatics-Driven Prediction of BACE-1 Inhibitors: Affinity and Molecular Mechanism Exploration

  2024cites this paper
• Moving Average-Based Multitasking In Silico Classification Modeling: Where Do We Stand and What Is Next?

  2022cites this paper
• Design and synthesis of novel phe-phe hydroxyethylene derivatives as potential coronavirus main protease inhibitors

  2021cites this paper
• The QSAR Paradigm in Fragment-Based Drug Discovery: From the Virtual Generation of Target Inhibitors to Multi-Scale Modeling.

  2020cites this paper
• Chemometric Modeling of Structurally Diverse Carbamates for the Inhibition of Acetylcholinesterase (AChE) Enzyme in Alzheimer's Disease

  2020cites this paper
• Multi-scale QSAR Approach for Simultaneous Modeling of Ecotoxic Effects of Pesticides

  2020cites this paper
• Multicellular Target QSAR Model for Simultaneous Prediction and Design of Anti-Pancreatic Cancer Agents

  2019cites this paper
• Multi-Target Chemometric Modelling, Fragment Analysis and Virtual Screening with ERK Inhibitors as Potential Anticancer Agents

  2019cites this paper
• Development of Multi-Target Chemometric Models for the Inhibition of Class I PI3K Enzyme Isoforms: A Case Study Using QSAR-Co Tool

  2019cites this paper
• Probing the Environmental Toxicity of Deep Eutectic Solvents and Their Components: An In Silico Modeling Approach

  2019cites this paper
• Virtual Screening in the Search of New and Potent Anti-Alzheimer Agents

  2018cites this paper
• Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease.

  2017cites this paper
• Rational Drug Design Rational Drug Design: One Target, Many Paths to It

  2017cites this paper
• Medical Application of Polyampholytes

  2017cites this paper
• The Role of Artificial Neural Networks on Target Validation in Drug Discovery and Development

  2016cites this paper
• Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer's disease.

  2015cites this paper
• From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer's Disease.

  2015cites this paper
• Medicinal Chemistry Approaches to Neglected Diseases Drug Discovery

  2014cites this paper
• Prediction of Multi-Target Networks of Neuroprotective Compounds with Entropy Indices and Synthesis, Assay, and Theoretical Study of New Asymmetric 1,2-Rasagiline Carbamates

  2014cites this paper
• Rational Drug Design: One Target, Many Paths to It

  2014cites this paper
• Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors.

  2014cites this paper
• Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer's Disease

  2014cites this paper
• From small to powerful: the fragments universe and its "chem-appeal".

  2013cites this paper
• Computation Of Hydrogen Bond Basicity As A Descriptor In Bioisosterism: A Quantum Chemical Topology Perspective.

  2013cites this paper
• Molecular Docking and Molecular Dynamics Simulations of the Kinase Domain Inhibitor for an Epidermal Growth Factor Receptor

  2013cites this paper
• Computational tools in the discovery of new G-quadruplex ligands with potential anticancer activity.

  2013cites this paper
• Advancement towards tin-based anticancer chemotherapeutics: structural modification and computer modeling approach to drug-enzyme interactions.

  2013cites this paper
• Abelson tyrosine-protein kinase 1 as principal target for drug discovery against leukemias. Role of the current computer-aided drug design methodologies.

  2013cites this paper
• Radical scavengers as ribonucleotide reductase inhibitors.

  2013cites this paper
• New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs.

  2013cites this paper
• Simultaneous modeling of antimycobacterial activities and ADMET profiles: a chemoinformatic approach to medicinal chemistry.

  2013cites this paper
• Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction.

  2013cites this paper
• Evolution of graph theory-based QSAR methods and their applications to the search for new antibacterial agents.

  2013cites this paper
• Editorial (Hot Topic: Computer-Aided Drug Design, Synthesis and Evaluation of New Anti-Cancer Drugs)

  2013cites this paper
• Unified multi-target approach for the rational in silico design of anti-bladder cancer agents.

  2013cites this paper
• Biologically active 4-thiazolidinones: a review of QSAR studies and QSAR modeling of antitumor activity.

  2013cites this paper
• SAR, QSAR and docking of anticancer flavonoids and variants: a review.

  2013cites this paper
• A REVIEW ON CURRENT INDUSTRIAL TRENDS FOR SYNTHESIS OF MEDICINAL COMPOUNDS

  2013cites this paper
• Are retinoids a promise for Alzheimer's disease management?

  2012cites this paper
• QSAR and molecular docking techniques for the discovery of potent monoamine oxidase B inhibitors: computer-aided generation of new rasagiline bioisosteres.

  2012cites this paper
• Computer-aided drug design, synthesis and evaluation of new anti-cancer drugs.

  2012cites this paper